Cadrenal Therapeutics, Inc.
CVKD
$10.63
$1.7719.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.54% | 10.59% | 11.72% | 19.23% | -52.09% |
| Total Receivables | -- | -- | -- | 2.69% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -39.49% | 52.58% | 95.92% | -19.27% | 13.70% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -22.33% | -86.06% | -94.93% | -- | -- |
| Total Current Assets | -12.69% | 9.71% | 13.04% | 19.08% | -49.64% |
|
|
|||||
| Total Current Assets | -12.69% | 9.71% | 13.04% | 19.08% | -49.64% |
| Net Property, Plant & Equipment | 90.00% | -56.57% | -71.69% | -70.39% | -89.93% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -42.11% | -42.11% | 0.00% | 0.00% | 0.00% |
| Total Assets | -12.65% | 9.55% | 12.84% | 18.83% | -49.75% |
|
|
|||||
| Total Accounts Payable | 23.61% | 17.92% | 219.28% | 798.09% | 250.60% |
| Total Accrued Expenses | -3.83% | 12.53% | 27.45% | 85.13% | 93.47% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -91.20% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 6.77% | 14.65% | 114.90% | 224.59% | 124.79% |
|
|
|||||
| Total Current Liabilities | 6.77% | 14.65% | 114.90% | 224.59% | 124.79% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.77% | 14.65% | 114.90% | 224.59% | 123.91% |
|
|
|||||
| Common Stock & APIC | 54.95% | 62.35% | 55.63% | 45.68% | 10.03% |
| Retained Earnings | -66.80% | -73.76% | -76.69% | -70.67% | -54.63% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -19.85% | 7.68% | -1.28% | -3.29% | -60.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -19.85% | 7.68% | -1.28% | -3.29% | -60.98% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -19.85% | 7.68% | -1.28% | -3.29% | -60.98% |
|
|
|||||